Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from a Pharmacovigilance Safety Database.

Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Förger F.

Arthritis Rheumatol. 2018 Apr 5. doi: 10.1002/art.40508. [Epub ahead of print]

PMID:
29623679
2.

Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis.

Curtis JR, Chen L, Danila MI, Saag KG, Parham KL, Cush JJ.

J Rheumatol. 2018 Jan;45(1):40-44. doi: 10.3899/jrheum.170548. Epub 2017 Nov 15.

PMID:
29142029
3.

Editorial: Herpes Zoster: Fear the Infection, Value the Solution.

Cush JJ.

Arthritis Rheumatol. 2017 Oct;69(10):1917-1920. doi: 10.1002/art.40188. No abstract available.

PMID:
28845573
4.

Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.

Clowse ME, Wolf DC, Förger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U.

J Rheumatol. 2015 Dec;42(12):2270-8. doi: 10.3899/jrheum.140189. Epub 2015 Nov 1.

5.

Pregnancy: Data, Outcomes, and Treatment Paradigms in Rheumatology.

Kavanaugh A, Cush JJ.

J Rheumatol. 2015 Aug;42(8):1357-8. doi: 10.3899/jrheum.150566. No abstract available.

PMID:
26233947
6.

Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.

Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):313-25. doi: 10.1002/acr.22516. No abstract available. Erratum in: Arthritis Care Res (Hoboken). 2015 May;67(5):738.

7.

Editorial: pregnancy and rheumatoid arthritis - do not let the perfect become the enemy of the good.

Cush JJ, Kavanaugh A.

Curr Opin Rheumatol. 2014 May;26(3):299-301. doi: 10.1097/BOR.0000000000000061. No abstract available.

PMID:
24667288
8.

RNA recognition by human TLR8 can lead to autoimmune inflammation.

Guiducci C, Gong M, Cepika AM, Xu Z, Tripodo C, Bennett L, Crain C, Quartier P, Cush JJ, Pascual V, Coffman RL, Barrat FJ.

J Exp Med. 2013 Dec 16;210(13):2903-19. doi: 10.1084/jem.20131044. Epub 2013 Nov 25.

9.

Autoinflammatory syndromes.

Cush JJ.

Dermatol Clin. 2013 Jul;31(3):471-80. doi: 10.1016/j.det.2013.05.001. Review.

10.

Proceedings of the 2013 Rheumatology Winter Clinical Symposia.

Kavanaugh A, Fleischmann R, Bergman MJ, Ruderman E, Troum O, Wells AF, Martin G, Calabrese LH, Gibofsky A, Strand V, Cush JJ.

Semin Arthritis Rheum. 2013 Jun;42(6):667-73. doi: 10.1016/j.semarthrit.2013.04.001. Review.

PMID:
23731828
11.

Refining drug safety in rheumatology.

Cush JJ, Dao KH.

Rheum Dis Clin North Am. 2012 Nov;38(4):xi-xiv. doi: 10.1016/j.rdc.2012.10.001.

PMID:
23137585
12.

Malignancy risks with biologic therapies.

Cush JJ, Dao KH.

Rheum Dis Clin North Am. 2012 Nov;38(4):761-70. doi: 10.1016/j.rdc.2012.09.006. Review.

PMID:
23137581
13.

Nonserious infections: should there be cause for serious concerns?

Dao KH, Herbert M, Habal N, Cush JJ.

Rheum Dis Clin North Am. 2012 Nov;38(4):707-25. doi: 10.1016/j.rdc.2012.08.016. Review.

PMID:
23137578
14.

Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.

Hsia EC, Cush JJ, Matteson EL, Beutler A, Doyle MK, Hsu B, Xu S, Rahman MU.

Arthritis Care Res (Hoboken). 2013 Feb;65(2):309-13. doi: 10.1002/acr.21788.

15.

IL-1 Trap rilonacept in refractory adult onset Still's disease.

Petryna O, Cush JJ, Efthimiou P.

Ann Rheum Dis. 2012 Dec;71(12):2056-7. doi: 10.1136/annrheumdis-2012-201409. Epub 2012 Jun 7. No abstract available.

PMID:
22679302
16.

Proceedings of the 2012 Rheumatology Winter Clinical Symposia.

Kavanaugh A, Martin G, Cush JJ, Bergman MJ, Fleischmann R, Troum OM, Strand V, Ruderman EM, Wells AF.

Semin Arthritis Rheum. 2012 Jun;41(6):923-6. doi: 10.1016/j.semarthrit.2012.03.002.

PMID:
22617482
17.

Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU.

Arthritis Rheum. 2012 Jul;64(7):2068-77. doi: 10.1002/art.34382.

18.

Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease.

Kavanaugh AF, Mayer LF, Cush JJ, Hanauer SB.

Am J Med. 2011 Apr;124(4 Suppl):e1-18. doi: 10.1016/j.amjmed.2011.01.001. Review. No abstract available.

PMID:
21531240
19.

Proceedings of the 2011 Rheumatology Winter Clinical Symposia--Arthur Kavanaugh, MD and John J. Cush, MD (proceedings editors) [course directors: Arthur Kavanaugh, MD, George Martin, MD].

Kavanaugh A, Cush JJ.

Semin Arthritis Rheum. 2011 Apr;40(5):479-81. doi: 10.1016/j.semarthrit.2011.03.001. No abstract available.

PMID:
21444001
20.

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, Cush JJ, Mejias A, Ramilo O, Kon OM, Pascual V, Banchereau J, Chaussabel D, O'Garra A.

Nature. 2010 Aug 19;466(7309):973-7. doi: 10.1038/nature09247.

21.

Can tumor necrosis factor inhibitors be safely used in pregnancy?

Ali YM, Kuriya B, Orozco C, Cush JJ, Keystone EC.

J Rheumatol. 2010 Jan;37(1):9-17. doi: 10.3899/jrheum.090563. Epub 2009 Dec 15. Review.

PMID:
20008917
22.

Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.

Cohen SB, Cohen MD, Cush JJ, Fleischmann RM, Mease PJ, Schiff MH, Simon LS, Weaver AL.

J Rheumatol Suppl. 2008 Feb;81:4-30; quiz 31-4. Review.

PMID:
19193621
23.

Early rheumatoid arthritis -- is there a window of opportunity?

Cush JJ.

J Rheumatol Suppl. 2007 Nov;80:1-7. Review.

PMID:
17985417
24.

Iatrogenic rheumatic syndromes in the elderly.

Quiceno GA, Cush JJ.

Rheum Dis Clin North Am. 2007 Feb;33(1):123-34. Review.

PMID:
17367696
25.

Acute polyarthritis.

Dao K, Cush JJ.

Best Pract Res Clin Rheumatol. 2006 Aug;20(4):653-72. Review.

PMID:
16979530
26.

Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO 3rd, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR Jr, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ.

N Engl J Med. 2006 Feb 23;354(8):795-808.

27.

Remodeling a rheumatology practice to facilitate early referral.

Cush JJ.

Rheum Dis Clin North Am. 2005 Nov;31(4):591-604. Review.

PMID:
16287586
28.

Laboratory monitoring of biologic therapies.

Cush JJ, Yazici Y.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S90-2.

PMID:
16273791
29.

Biological drug use: US perspectives on indications and monitoring.

Cush JJ.

Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv18-23.

30.

Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.

Davis JC Jr, Van der Heijde DM, Dougados M, Braun J, Cush JJ, Clegg DO, Inman RD, de Vries T, Tsuji WH.

J Rheumatol. 2005 Sep;32(9):1751-4.

PMID:
16142873
31.

Iatrogenic rheumatic syndromes in the elderly.

Quiceno GA, Cush JJ.

Clin Geriatr Med. 2005 Aug;21(3):577-88, vii. Review.

PMID:
15911208
32.

Early arthritis clinics: if you build it will they come?

Cush JJ.

J Rheumatol. 2005 Feb;32(2):203-7. No abstract available.

PMID:
15693079
33.

Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus.

Cush JJ.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S141-7. Review.

PMID:
15552528
34.

The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis.

Kavanaugh A, Cohen S, Cush JJ.

J Rheumatol. 2004 Oct;31(10):1881-4. No abstract available.

PMID:
15468347
35.

Safety overview of new disease-modifying antirheumatic drugs.

Cush JJ.

Rheum Dis Clin North Am. 2004 May;30(2):237-55, v. Review.

PMID:
15172038
36.

The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.

Hansen KE, Hildebrand JP, Genovese MC, Cush JJ, Patel S, Cooley DA, Cohen SB, Gangnon RE, Schiff MH.

J Rheumatol. 2004 Jun;31(6):1098-102.

PMID:
15170921
37.

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.

Cohen SB, Moreland LW, Cush JJ, Greenwald MW, Block S, Shergy WJ, Hanrahan PS, Kraishi MM, Patel A, Sun G, Bear MB; 990145 Study Group.

Ann Rheum Dis. 2004 Sep;63(9):1062-8. Epub 2004 Apr 13.

38.

Early arthritis clinic: a USA perspective.

Cush JJ.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S75-8. Review.

PMID:
14969055
39.

Rationale and risks of novel immunomodulatory therapies in rheumatoid arthritis.

Cush JJ.

Drugs Today (Barc). 1999 Apr-May;35(4-5):287-94.

PMID:
12973433
40.

Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.

Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM.

Ann Intern Med. 2002 Nov 5;137(9):726-33.

PMID:
12416946
41.
42.

Consensus recommendations for the assessment and treatment of rheumatoid arthritis.

Wolfe F, Cush JJ, O'Dell JR, Kavanaugh A, Kremer JM, Lane NE, Moreland LW, Paulus HE, Pincus T, Russell AS, Wilskie KR.

J Rheumatol. 2001 Jun;28(6):1423-30. Review. No abstract available.

PMID:
11409141
43.

Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells.

Davis LS, Cush JJ, Schulze-Koops H, Lipsky PE.

Arthritis Res. 2001;3(1):54-64. Epub 2000 Nov 2.

44.

Adult-onset Still's disease.

Cush JJ.

Bull Rheum Dis. 2000;49(6):1-4. No abstract available.

PMID:
11100625
45.

US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis.

Cush JJ, Tugwell P, Weinblatt M, Yocum D.

J Rheumatol. 1999 May;26(5):1176-86.

PMID:
10332987
46.

An evidence-based medicine approach to the diagnosis and management of musculoskeletal complaints.

Ellrodt AG, Cho M, Cush JJ, Kavanaugh AF, Lipsky PE.

Am J Med. 1997 Dec 29;103(6A):3S-6S. Review.

PMID:
9455962
47.

Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study.

Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, Budiman-Mak E, Balestra DJ, Blackburn WD, Cannon GW, Inman RD, Alepa FP, Mejias E, Cohen MR, Makkena R, Mahowald ML, Higashida J, Silverman SL, Parhami N, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Henderson WG, et al.

Arthritis Rheum. 1996 Dec;39(12):2021-7.

PMID:
8961907
48.

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, Budiman-Mak E, Blackburn WD, Vasey FB, Mahowald ML, Cush JJ, Schumacher HR Jr, Silverman SL, Alepa FP, Luggen ME, Cohen MR, Makkena R, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Henderson WG.

Arthritis Rheum. 1996 Dec;39(12):2013-20.

PMID:
8961906
49.

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.

Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, Mahowald ML, Schumacher HR Jr, Taylor T, Budiman-Mak E, Cohen MR, Vasey FB, Luggen ME, Mejias E, Silverman SL, Makkena R, Alepa FP, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Henderson WG.

Arthritis Rheum. 1996 Dec;39(12):2004-12.

PMID:
8961905
50.

A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator Group.

Olsen NJ, Brooks RH, Cush JJ, Lipsky PE, St Clair EW, Matteson EL, Gold KN, Cannon GW, Jackson CG, McCune WJ, Fox DA, Nelson B, Lorenz T, Strand V.

Arthritis Rheum. 1996 Jul;39(7):1102-8. Erratum in: Arthritis Rheum 1996 Sep;39(9):1575.

PMID:
8670317

Supplemental Content

Support Center